Principles of brain tumor chemotherapy.
Shapiro
W R
WR
Shapiro
J R
JR
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002250:Carbon Radioisotopes; D002330:Carmustine / Q000627:therapeutic use; D002460:Cell Line; D002945:Cisplatin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D005472:Fluorouracil / Q000627:therapeutic use; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007261:Infusions, Intra-Arterial; D007621:Karyotyping; D007700:Kinetics; D008353:Mannitol / Q000494:pharmacology; D008727:Methotrexate / Q000378:metabolism; D011034:Podophyllotoxin / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D051381:Rats; D014410:Tumor Stem Cell Assay
D000970:Antineoplastic Agents; D002250:Carbon Radioisotopes; D011344:Procarbazine; D008353:Mannitol; D011034:Podophyllotoxin; D002945:Cisplatin; D005472:Fluorouracil; D002330:Carmustine; D006918:Hydroxyurea; D008727:Methotrexate